Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diseases of the Thyroid
  Free Subscription

Articles published in
J Clin Endocrinol Metab
    April 2026

  1. Correction to: "Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2026 Apr 29:dgag166. doi: 10.1210.
    >> Share

  2. LARIOS F, Borras-Osorio M, Wu Y, Claros AG, et al
    Artificial Intelligence-Enabled Analysis of Radiology Reports: Epidemiology and Outcomes of Incidental Thyroid Findings.
    J Clin Endocrinol Metab. 2026 Apr 27:dgag186. doi: 10.1210.
    >> Share

  3. WASSERMAN JD, Isaza AR, Waguespack SG, Wassner AJ, et al
    The Landscape of Pediatric Differentiated Thyroid Carcinoma and Predictors of Invasive Disease: A CATC Study.
    J Clin Endocrinol Metab. 2026 Apr 22:dgag172. doi: 10.1210.
    >> Share

  4. GRAF KE, Adam P, Megerle F, Machlah YM, et al
    Outcome Of First-Line Chemotherapy For Anaplastic Thyroid Cancer - A Multicenter Registry Analysis.
    J Clin Endocrinol Metab. 2026 Apr 21:dgag177. doi: 10.1210.
    >> Share

  5. MONETA C, Trevisan M, Colombo C, De Luca A, et al
    VALIDATION OF THE 2025 ATA RISK STRATIFICATION SYSTEM IN A COHORT OF PATIENTS WITH PAPILLARY THYROID CARCINOMA.
    J Clin Endocrinol Metab. 2026 Apr 17:dgag167. doi: 10.1210.
    >> Share

  6. AO L, Noordam R, Trompet S, van Vliet NA, et al
    Levothyroxine treatment response of cardiometabolic biomarkers in older adults with subclinical hypothyroidism.
    J Clin Endocrinol Metab. 2026 Apr 8:dgag155. doi: 10.1210.
    >> Share

  7. COPERCHINI F, Greco A, Franchi E, Denegri M, et al
    Studying endocrine disrupting chemicals from molecular targets to mixture model approach: lessons from the thyroid model.
    J Clin Endocrinol Metab. 2026 Apr 8:dgag149. doi: 10.1210.
    >> Share

    March 2026
  8. ABBATE M, Vincenzi G, Mora S, Tarantola G, et al
    The FT3/FT4 Ratio Predicts Relapse After Antithyroid Drug Withdrawal in Pediatric Autoimmune Hyperthyroidism.
    J Clin Endocrinol Metab. 2026 Mar 31:dgag130. doi: 10.1210.
    >> Share

  9. CHEN Y, Du F, Singh Ospina NM, Brito JP, et al
    Patterns of Thyroid-Stimulating Hormone Test After GLP-1 RAs Initiation in Patients on Levothyroxine: A Trial Emulation Study.
    J Clin Endocrinol Metab. 2026 Mar 27:dgag131. doi: 10.1210.
    >> Share

  10. MINALDI E, Ramone T, Ciampi R, Romei C, et al
    Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment.
    J Clin Endocrinol Metab. 2026 Mar 27:dgag074. doi: 10.1210.
    >> Share

  11. SMITH AH, Priscu A, Morkos M
    Initial Disease Severity and Methimazole Titration for Graves' Disease: A Retrospective Longitudinal Cohort Study.
    J Clin Endocrinol Metab. 2026 Mar 26:dgag134. doi: 10.1210.
    >> Share

  12. VAN TWIST DJL, Willems JIA, Tummers-de Lind van Wijngaarden RFA
    Response to Letter of the Editor "Fasting vs Non-fasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2026 Mar 20:dgag128. doi: 10.1210.
    >> Share

  13. VIRILI C, Trimboli P, Centanni M
    Letter to the Editor from Virili at al: "Fasting vs Non-fasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2026 Mar 20:dgag127. doi: 10.1210.
    >> Share

  14. SALEH L, Schreurs MWJ, Boersma E, Drexhage HA, et al
    Maternal TSH-receptor antibodies predict fetal/neonatal hyperthyroidism in pregnancies with a history of Graves' disease.
    J Clin Endocrinol Metab. 2026 Mar 18:dgag118. doi: 10.1210.
    >> Share

  15. KOSTOPOULOS G, Effraimidis G
    Approach to the patient with severe hyperthyroidism-related complications.
    J Clin Endocrinol Metab. 2026 Mar 13:dgag112. doi: 10.1210.
    >> Share

    February 2026
  16. CANBERK S, Baloch ZW, Isaza A, Bojarsky M, et al
    Age-Specific Risk of Malignancy in Pediatric Thyroid Cytology: Reframing ROM based on pre-test probability.
    J Clin Endocrinol Metab. 2026 Feb 25:dgag073. doi: 10.1210.
    >> Share

  17. MOMO HD, Haymart MR, Shi X, Mondul AM, et al
    Associations Between Radioactive Iodine Treatment for Hyperthyroidism and Cancer Incidence and Mortality.
    J Clin Endocrinol Metab. 2026 Feb 17:dgag058. doi: 10.1210.
    >> Share

  18. PATRIZIO A, Mauguen A, Fagin JA, Farooki A, et al
    Exposure to GLP-1RA and risk of structural progression in differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2026 Feb 15:dgag051. doi: 10.1210.
    >> Share

  19. TORO-TOBON D
    The Prediction Paradox: AI, Genetics, and Occult Metastasis in Thyroid Cancer.
    J Clin Endocrinol Metab. 2026 Feb 15:dgag065. doi: 10.1210.
    >> Share

  20. PRETE A, Matrone A, Romei C, Gambale C, et al
    Calcitonin Thresholds for Prediction of Medullary Thyroid Carcinoma and its Clinical Response in MEN2A Gene Carriers.
    J Clin Endocrinol Metab. 2026 Feb 14:dgag041. doi: 10.1210.
    >> Share

  21. CASTELLANOS LE, Bryan J, Ricarte-Filho JC, Franco AT, et al
    Afirma Genomic Sequencing Classifier Performance in Young Patients with Cytologically Indeterminate Thyroid Nodules.
    J Clin Endocrinol Metab. 2026 Feb 12:dgag059. doi: 10.1210.
    >> Share

  22. FORBES S, Loo M, Tee SA, Stewart K, et al
    Cigarette Smoking Exposure and Clinical Outcomes in Graves' Disease.
    J Clin Endocrinol Metab. 2026 Feb 12:dgag061. doi: 10.1210.
    >> Share

  23. KOPP PA, Giordani I, Feldt-Rasmussen U, Forget-Renaud A, et al
    Approach to the Patient with Thyroid Storm.
    J Clin Endocrinol Metab. 2026 Feb 7:dgag054. doi: 10.1210.
    >> Share

  24. AHMADI S, Kotwal A, Bikas A, Altshuler BF, et al
    Utility of Genomic Sequencing Classifier in Managing Cytologically Indeterminate Oncocytic Thyroid Nodules.
    J Clin Endocrinol Metab. 2026 Feb 6:dgag044. doi: 10.1210.
    >> Share

  25. REINHARDT C, Fotovat N, Siddiqui O, Ong J, et al
    Approach to the Patient: Therapeutic Mitigation of Lacrimal Manifestations in Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2026 Feb 6:dgag045. doi: 10.1210.
    >> Share

  26. ANDERSEN SL, Torp NMU, Vestergaard P, Andersen S, et al
    Hyperthyroidism and birth defects: The roles of maternal thyroid function and thyroid autoantibody positivity.
    J Clin Endocrinol Metab. 2026 Feb 4:dgag046. doi: 10.1210.
    >> Share

  27. UNUANE D, Velkeniers B, Poppe KG
    Thyroid Disorders and Female Infertility.
    J Clin Endocrinol Metab. 2026 Feb 3:dgag039. doi: 10.1210.
    >> Share

  28. LANZOLLA G, Saba F, Corrias S, Lixi F, et al
    Subclinical Ocular Alterations in Graves' Disease: The FUMO Score, a New Tool to Predict Graves' Orbitopathy Progression.
    J Clin Endocrinol Metab. 2026 Feb 2:dgag037. doi: 10.1210.
    >> Share

    January 2026
  29. LADO-ABEAL J, Munir I, Al-Zubaidi K, Mohammed S, et al
    Heart ventricular function in hospitalized patients with severe hypothyroidism and myxedema coma.
    J Clin Endocrinol Metab. 2026 Jan 30:dgag036. doi: 10.1210.
    >> Share


  30. Correction to: "Fasting vs Nonfasting, Dose-adjusted Levothyroxine Ingestion in Hypothyroidism: A Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2026 Jan 28:dgag020. doi: 10.1210.
    >> Share

  31. FINNEGAN EA, Ganly I
    Approach to the Patient: Oncocytic Thyroid Cancer.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag025. doi: 10.1210.
    >> Share

  32. LAW LS, Kuu NWX, Leong MHT, Lo EAG, et al
    Beyond the Gut: Thyroxine Malabsorption, Pharmacokinetics, and Delivery.
    J Clin Endocrinol Metab. 2026 Jan 23:dgag024. doi: 10.1210.
    >> Share


  33. Correction to: "Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves' Disease".
    J Clin Endocrinol Metab. 2026 Jan 22:dgag016. doi: 10.1210.
    >> Share

  34. CALDERON A, Aguilera M, Drinnon AR, Patham B, et al
    Therapeutic Plasma Exchange in Severe Thyrotoxicosis: Clinical Observations From a Case Series.
    J Clin Endocrinol Metab. 2026 Jan 20:dgaf649. doi: 10.1210.
    >> Share

  35. STAN MN, Toro-Tobon D
    Graves' Disease: A New Era of Pathophysiology-Guided Therapeutics.
    J Clin Endocrinol Metab. 2026 Jan 13:dgag010. doi: 10.1210.
    >> Share

  36. BOELAERT K, Bauer A, Cappola AR, Chatterjee K, et al
    Thyrotoxicosis in MCT8 deficiency.
    J Clin Endocrinol Metab. 2026 Jan 9:dgaf707. doi: 10.1210.
    >> Share

  37. MARAKA S, Papaleontiou M
    Approach to the Patient Considering Thyroid Hormone Deprescribing.
    J Clin Endocrinol Metab. 2026 Jan 3:dgaf697. doi: 10.1210.
    >> Share

    December 2025
  38. MEHROTRA-VARMA S, Hadidchi R, Henry S, Quangnguyen H, et al
    Elevated risk of new-onset thyroid disease associated with SARS-CoV-2 infection: a 4.5-year observational study.
    J Clin Endocrinol Metab. 2025 Dec 23:dgaf688. doi: 10.1210.
    >> Share

  39. WILLEMS JIA, van Twist DJL, Helmich F, Sluiter T, et al
    Fasting vs. Non-Fasting, Dose-Adjusted Levothyroxine Ingestion In Hypothyroidism: A Randomized Clinical Trial.
    J Clin Endocrinol Metab. 2025 Dec 23:dgaf686. doi: 10.1210.
    >> Share

  40. DE LIMA BELTRAO FE, Bianco AC
    Response to Letter to the Editor from Hedberg et al: "Treatment of Hypothyroidism That Contains Liothyronine Is Associated With Reduced Risk of Dementia and Mortality".
    J Clin Endocrinol Metab. 2025 Dec 22:dgaf669. doi: 10.1210.
    >> Share

  41. HEDBERG F, Calissendorff J, Falhammar H, Ueda P, et al
    Letter to the Editor from Hedberg et al: Treatment of Hypothyroidism That Contains Liothyronine Is Associated with Reduced Risk of Dementia and Mortality.
    J Clin Endocrinol Metab. 2025 Dec 22:dgaf656. doi: 10.1210.
    >> Share

  42. KAMITANI F, Nishioka Y, Nakajima H, Kurematsu Y, et al
    Multiple or Single Endocrine Abnormalities Associated With Immune Checkpoint Inhibitors.
    J Clin Endocrinol Metab. 2025;111:54-61.
    >> Share

  43. NELSON HA, Doyle K, Straseski JA
    TSH Receptor Antibody Test Utilization Patterns From a National Reference Laboratory: TRAb, TSI, or Both?
    J Clin Endocrinol Metab. 2025;111:e92-e99.
    >> Share

  44. MACHLAH YM, Brandenburg T, Muchalla P, Tiedje V, et al
    Comprehensive Assessment of Multikinase Inhibitor Therapy Outcomes in RAIR-(P)DTC and MTC at a Tertiary Referral Center.
    J Clin Endocrinol Metab. 2025;111:167-179.
    >> Share

  45. ANGELOPOULOS N, Goulis DG, Chrisogonidis I, Iakovou I, et al
    Elastography enhances diagnostic accuracy of ACR TI-RADS in thyroid nodule evaluation.
    J Clin Endocrinol Metab. 2025 Dec 18:dgaf670. doi: 10.1210.
    >> Share

  46. EVRON J, Moretti B, Evans R, Burns J, et al
    Association between Over- and Under-Replacement with Thyroid Hormone and Incident Heart Failure.
    J Clin Endocrinol Metab. 2025 Dec 17:dgaf677. doi: 10.1210.
    >> Share

  47. ETTLESON MD, Thomas N, Wan W, Hedeker D, et al
    Suboptimal levothyroxine treatment is associated with increases in mean blood pressure and blood pressure variability.
    J Clin Endocrinol Metab. 2025 Dec 17:dgaf675. doi: 10.1210.
    >> Share


  48. Correction to: "Quality of Life in Patients With Hypoparathyroidism After Treatment for Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Dec 12:dgaf657. doi: 10.1210.
    >> Share

  49. WANG Z, Yang S, Li Y, Tian J, et al
    An Interpretable Machine Learning Model for Predicting Occult Central Lymph Node Metastasis in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Dec 11:dgaf636. doi: 10.1210.
    >> Share

  50. WOLF J, Lorenz K, Othman AE, Beck A, et al
    Secukinumab in Moderate-to-Severe Graves' Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
    J Clin Endocrinol Metab. 2025 Dec 9:dgaf655. doi: 10.1210.
    >> Share

  51. MIRJALILI SR, Razmpoosh E, Eshraghi R, Ashoori M, et al
    Comparative Efficacy of Radioiodine Therapy With Adjunctive Thionamides vs Either Treatment Alone in the Management of Graves Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2025 Dec 1:dgaf580. doi: 10.1210.
    >> Share

    November 2025
  52. ELBEDOUR L, Weinberg M, Meiri G, Michaelovski A, et al
    Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder.
    J Clin Endocrinol Metab. 2025 Nov 25:dgaf596. doi: 10.1210.
    >> Share

  53. DAN R, Paran N, Vinegrad N, Fraenkel M, et al
    Parity as a Risk Factor for Differentiated Thyroid Carcinoma- A Population-Based Study.
    J Clin Endocrinol Metab. 2025 Nov 24:dgaf642. doi: 10.1210.
    >> Share

  54. GARZA B, Calhoun J, Norman P, Cline N, et al
    Tumor-infiltrating T Lymphocytes Recognize Thyroid-specific and Neo-antigens in Follicular Cell-derived Thyroid Cancers.
    J Clin Endocrinol Metab. 2025 Nov 22:dgaf639. doi: 10.1210.
    >> Share

  55. LEE JS, Kim NK, Jeong HJ, Yun HJ, et al
    Impact of Subtype Variability on Clinical Features in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Nov 19:dgaf531. doi: 10.1210.
    >> Share

  56. YU CY, Chu EH, Lin CH, Chen YC, et al
    Diagnostic Efficiency of Thyroglobulin in Lymph Node Fine-needle Aspiration Washout: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2025;110:3569-3587.
    >> Share

  57. STERENBORG RBTM, Peeters RP, Visser E, Kus A, et al
    Genetics of Thyroid Function: Relevance for Biology and Disease Management.
    J Clin Endocrinol Metab. 2025 Nov 18:dgaf491. doi: 10.1210.
    >> Share

  58. SOTO JACOME C, Arce-Camposano A, Toro-Tobon D, Al Zahidy M, et al
    Drug Repurposing for Reducing the Size of Benign Thyroid Nodules: A Systematic Review.
    J Clin Endocrinol Metab. 2025 Nov 12:dgaf616. doi: 10.1210.
    >> Share

  59. DOBNIG H, Amrein K
    Mid- to Long-term Outcomes After Single Radiofrequency Ablation of Non-Toxic and Toxic Thyroid Nodules.
    J Clin Endocrinol Metab. 2025 Nov 4:dgaf611. doi: 10.1210.
    >> Share

    October 2025
  60. HABIB S, Perez Rodriguez Garcia G, Zhang Z, Roy A, et al
    Determining Thyroid Biopsy Appropriateness: A Retrospective Study Integrating Clinical Context and Ultrasound Features.
    J Clin Endocrinol Metab. 2025 Oct 24:dgaf577. doi: 10.1210.
    >> Share

  61. GAMBELUNGHE G, Del Sindaco P, Morettini F, Ristagno S, et al
    Percutaneous Laser Ablation for Thyroid Nodules: Efficacy and Safety in 1,492 Patients with Median Follow-up >/= 10 Years.
    J Clin Endocrinol Metab. 2025 Oct 24:dgaf581. doi: 10.1210.
    >> Share

  62. MORAN C, Martin-Grace J, Lyons G, Watson L, et al
    TRIAC therapy relieves hyperthyroid symptoms, lowering T4, T3 and metabolic rate in Resistance to Thyroid Hormone beta.
    J Clin Endocrinol Metab. 2025 Oct 23:dgaf583. doi: 10.1210.
    >> Share

  63. BAHL S, Taylor PN, Premawardhana LD, Stedman M, et al
    Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2025;110:3278-3288.
    >> Share

  64. CASALINI R, Romei C, Bottici V, Cappagli V, et al
    Prevalence and genetics of "de novo" MEN2 syndromes.
    J Clin Endocrinol Metab. 2025;110:e3559-e3565.
    >> Share

  65. NAKATANI R, Watabe T, Fukuhara A, Takano T, et al
    Initial evaluation of radioiodine therapy using Imaging for long-term prognosis in thyroid cancer: A retrospective study.
    J Clin Endocrinol Metab. 2025 Oct 15:dgaf568. doi: 10.1210.
    >> Share

  66. KIM JY, Lee K, Choi E, Oh JS, et al
    Development of a Machine Learning-Based Model for Methimazole Dosage Adjustment in Youth with Hyperthyroidism.
    J Clin Endocrinol Metab. 2025 Oct 7:dgaf542. doi: 10.1210.
    >> Share

  67. RITTER A, Eagan A, Levyn H, Tuttle RM, et al
    Comparable Outcomes of Differentiated Thyroid Cancer in Immunocompromised versus Immunocompetent Patients.
    J Clin Endocrinol Metab. 2025 Oct 7:dgaf550. doi: 10.1210.
    >> Share

    September 2025
  68. ISLAM MS, Louzada Neto RA, Bouviere J, Ahmed AE, et al
    Functional Domain Mapping of TPO: Insights from Six Variants in Sudanese Kindreds with Congenital Hypothyroidism.
    J Clin Endocrinol Metab. 2025 Sep 26:dgaf536. doi: 10.1210.
    >> Share

  69. POZDEYEV N, White SL, Bell CC, Haugen BR, et al
    Artificial intelligence applications in thyroid cancer care.
    J Clin Endocrinol Metab. 2025 Sep 25:dgaf530. doi: 10.1210.
    >> Share

  70. VALENCIAGA A, Liyanarachchi S, Brock PL, Ringel MD, et al
    Long-term outcomes of patients diagnosed with differentiated thyroid cancer in childhood and young adulthood.
    J Clin Endocrinol Metab. 2025 Sep 18:dgaf522. doi: 10.1210.
    >> Share

  71. XU X, Zhang C, Wang G, Dong B, et al
    Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC.
    J Clin Endocrinol Metab. 2025;110:e3245-e3251.
    >> Share

  72. MENEGHINI V, de Lima Beltrao FE, Golovko G, Watson RK, et al
    Adverse outcomes in patients with hypothyroidism undergoing bariatric surgery: A retrospective study using TriNetX.
    J Clin Endocrinol Metab. 2025 Sep 16:dgaf519. doi: 10.1210.
    >> Share

  73. JONKLAAS J
    Safe optimization of thyroid hormone therapy.
    J Clin Endocrinol Metab. 2025 Sep 10:dgaf512. doi: 10.1210.
    >> Share

  74. VILLAGELIN D, Cooper DS
    Low Dose Methimazole in the Long-Term Management of Graves' Disease: Small doses, big benefits.
    J Clin Endocrinol Metab. 2025 Sep 10:dgaf503. doi: 10.1210.
    >> Share

  75. WEI M, Mehravar S, Leite G, Naji P, et al
    Relationship between hypothyroidism, risk of small intestinal bacterial overgrowth, and duodenal microbiome alterations.
    J Clin Endocrinol Metab. 2025 Sep 5:dgaf495. doi: 10.1210.
    >> Share

  76. REDLICH A, Pfaehler E, Kunstreich M, Schmutz M, et al
    ML Prediction of Recurrence in Pediatric Thyroid Cancer: MET Cohort Analysis Using XGBoost and SHAP.
    J Clin Endocrinol Metab. 2025 Sep 1:dgaf487. doi: 10.1210.
    >> Share

    August 2025
  77. CHUBB SAP, Davis WA, Davis TME
    Effects of subclinical hypothyroidism on nephropathy complicating type 2 diabetes: The Fremantle Diabetes Study Phase II.
    J Clin Endocrinol Metab. 2025 Aug 29:dgaf485. doi: 10.1210.
    >> Share

  78. CHO YY, Ahn SH, Kim M, Lee EK, et al
    TSH Cut-Offs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2025 Aug 14:dgaf463. doi: 10.1210.
    >> Share

  79. YANG L, Sato M, Saito-Abe M, Miyaji Y, et al
    Association Between Particulate Matter Exposure and Thyroid Hormone Levels in Early Childhood: Results from JECS.
    J Clin Endocrinol Metab. 2025 Aug 6:dgaf446. doi: 10.1210.
    >> Share

  80. MIYAMURA K, Ito M, Yamaoka H, Hisakado M, et al
    Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf433. doi: 10.1210.
    >> Share

    July 2025
  81. XU Y, Licher S, Visser WE, Bakker SJL, et al
    Thyroid function and all-cause mortality in the context of multimorbidity: results from two population-based studies.
    J Clin Endocrinol Metab. 2025 Jul 25:dgaf425. doi: 10.1210.
    >> Share

  82. NAKHLEH A, Robenshtok E, Adler L, Ben David SS, et al
    Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism.
    J Clin Endocrinol Metab. 2025 Jul 25:dgaf426. doi: 10.1210.
    >> Share

  83. LONG X
    Letter to the Editor from Long: "Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom Population (ACEL-UK): Cohort Study".
    J Clin Endocrinol Metab. 2025 Jul 21:dgaf419. doi: 10.1210.
    >> Share


  84. Correction to: "Efficacy and Safety of Targeted Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Jul 21:dgaf407. doi: 10.1210.
    >> Share

  85. CHIARDI I, Croce L, Caccavale P, Bertini J, et al
    Establishing the adequate levothyroxine dose after total thyroidectomy: A systematic review with meta-analysis.
    J Clin Endocrinol Metab. 2025 Jul 19:dgaf417. doi: 10.1210.
    >> Share

  86. MAINO F, Mattii E, Castagna MG
    Letter to the Editor from Maino et al.: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-Analysis".
    J Clin Endocrinol Metab. 2025 Jul 18:dgaf411. doi: 10.1210.
    >> Share

  87. SCAPPATICCIO L, Di Martino N, Ferrazzano P, Maiorino MI, et al
    Response to Letter to the Editor from Maino et al.: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-Analysis".
    J Clin Endocrinol Metab. 2025 Jul 18:dgaf412. doi: 10.1210.
    >> Share

  88. GREENSPUN BC, Metzger DA, Lee S, Pearson BE, et al
    Long Term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model.
    J Clin Endocrinol Metab. 2025 Jul 15:dgaf391. doi: 10.1210.
    >> Share

  89. BODOQUE-CUBAS J, Fernandez-Saez J, Martinez-Hervas S, Perez-Lacasta MJ, et al
    Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-Effectiveness Analysis.
    J Clin Endocrinol Metab. 2025 Jul 12:dgaf399. doi: 10.1210.
    >> Share

  90. ETTLESON MD, Thomas N, Ramirez M, Wan W, et al
    Measuring hypothyroidism disease control using a TSH-based "time-in-range".
    J Clin Endocrinol Metab. 2025 Jul 12:dgaf393. doi: 10.1210.
    >> Share


  91. Correction to: "Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence".
    J Clin Endocrinol Metab. 2025 Jul 3:dgaf380. doi: 10.1210.
    >> Share

    June 2025
  92. HAMIDI S, Maniakas A, Akhave NS, Banuchi VE, et al
    Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues.
    J Clin Endocrinol Metab. 2025 Jun 26:dgaf366. doi: 10.1210.
    >> Share

  93. BELTRAO FEL, Carvalhal G, Meneghini V, Matos DAR, et al
    Treatment of Hypothyroidism that Contains Liothyronine is Associated with Reduced Risk of Dementia and Mortality.
    J Clin Endocrinol Metab. 2025 Jun 20:dgaf367. doi: 10.1210.
    >> Share

  94. KIZILGUL M, Yigit T, Ata N, Celik A, et al
    Machine Learning Prediction of Pancreatitis Risk With Antithyroid Drugs: A Nationwide Retrospective Observational Study.
    J Clin Endocrinol Metab. 2025;110:2024-2030.
    >> Share

  95. MULDER TA, Muetzel RL, Peeters RP, Tiemeier H, et al
    Maternal thyroid function during pregnancy and early adolescent regional differences in cerebral gray matter morphology.
    J Clin Endocrinol Metab. 2025 Jun 16:dgaf349. doi: 10.1210.
    >> Share

  96. SUGISAWA C, Uehara E, Tanase-Nakao K, Inoue K, et al
    Clinical and Genetic Characteristics of Adult Nonautoimmune Hypothyroidism: A Single-Institution Study.
    J Clin Endocrinol Metab. 2025 Jun 12:dgaf352. doi: 10.1210.
    >> Share

  97. TOLOZA FJK, Gummalla S, Maraka S
    Levothyroxine in Pregnancy: Protective Neurodevelopmental Role Beyond Cognitive Outcomes?
    J Clin Endocrinol Metab. 2025 Jun 11:dgaf351. doi: 10.1210.
    >> Share

  98. HEDBERG F, Lindh JD, Mannheimer B, Planck T, et al
    Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2025 Jun 7:dgaf337. doi: 10.1210.
    >> Share

  99. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2025 Jun 4:dgaf326. doi: 10.1210.
    >> Share

  100. KU EJ, Lee J, Yoo WS, Bae J, et al
    Response to Letter to the Editor From Yan and Chang: "Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy".
    J Clin Endocrinol Metab. 2025 Jun 2:dgaf317. doi: 10.1210.
    >> Share

  101. YAN B, Chang S
    Letter to the Editor from Yan and Chang: "Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy".
    J Clin Endocrinol Metab. 2025 Jun 2:dgaf316. doi: 10.1210.
    >> Share

    May 2025
  102. NISHIKAWA Y, Oguro F, Suzuki C, Kobashi Y, et al
    Stable iodine intake and thyroid screening outcomes after the Fukushima Nuclear Disaster: an observational study.
    J Clin Endocrinol Metab. 2025 May 29:dgaf312. doi: 10.1210.
    >> Share

  103. FRICH PS, Sigstad E, Berstad AE, Opsahl EM, et al
    Ethanol Ablation of Metastatic Lymph Nodes in Patients with Papillary Thyroid Carcinoma - Predictors of Clinical Outcome.
    J Clin Endocrinol Metab. 2025 May 23:dgaf298. doi: 10.1210.
    >> Share

  104. THOMSEN MJ, Uldall Torp NM, Carle A, Karmisholt J, et al
    Hypothyroidism in Danish pregnant women across decades.
    J Clin Endocrinol Metab. 2025 May 21:dgaf300. doi: 10.1210.
    >> Share

  105. HAI Y, Ma Q, Fang S, Bahramimehr F, et al
    High-Throughput Proteomics and Immunohistochemistry of Orbital Connective Tissue in Graves' Orbitopathy.
    J Clin Endocrinol Metab. 2025 May 21:dgaf299. doi: 10.1210.
    >> Share

  106. YIN Q, Zhu T, Song D, Fang S, et al
    Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED.
    J Clin Endocrinol Metab. 2025;110:1537-1549.
    >> Share

  107. JING G, Tang J, Li Y, Li Y, et al
    Thyrotrophin receptor antibody: objective and quantitative inflammatory indicator in patients with thyroid eye disease.
    J Clin Endocrinol Metab. 2025 May 9:dgaf273. doi: 10.1210.
    >> Share

  108. MCNABB CB, Scholz A, Bloomfield L, Bhargava R, et al
    Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on brain microstructure.
    J Clin Endocrinol Metab. 2025 May 9:dgaf277. doi: 10.1210.
    >> Share

  109. GAO Y, Du C, Xu Y, Cheng X, et al
    Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-Related Hypothyroidism: A Retrospective Study.
    J Clin Endocrinol Metab. 2025 May 3:dgaf260. doi: 10.1210.
    >> Share

    April 2025
  110. BUJNIS M, DeSalvo K, Neklason DW, Madsen MJ, et al
    Familial risk of Hashimoto's thyroiditis in a large genealogical database.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf251. doi: 10.1210.
    >> Share

  111. WHITE SL, Jamil T, Bell C, Fishbein L, et al
    Population prevalence of the major thyroid cancer-associated syndromes.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf236. doi: 10.1210.
    >> Share

  112. HIRUMA S, Watanabe N, Noh JY, Hirose R, et al
    Occurrence of Newly Diagnosed Thyroid Cancer Is Not Increased After Radioactive Iodine Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf231. doi: 10.1210.
    >> Share

  113. ZHANG M, Qi X, Zhou X, Liu Y, et al
    A preclinical state of Graves' ophthalmopathy characterized by hypoxia of T-cells identified via multi-omics analysis.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf230. doi: 10.1210.
    >> Share

  114. KONDA B, Sherman EJ, Massarelli E, Nieva J, et al
    Response to Letter to the Editor from Zhang et al.: Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2025 Apr 4:dgaf221. doi: 10.1210.
    >> Share

  115. ZHANG Y, Zhao Y, Deng T, Meng W, et al
    Letter to the Editor from Zhang et al.: 'Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer'.
    J Clin Endocrinol Metab. 2025 Apr 4:dgaf220. doi: 10.1210.
    >> Share

  116. HOLLEY M, Razvi S, Maxwell I, Dew R, et al
    Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom population (ACEL-UK): Cohort Study.
    J Clin Endocrinol Metab. 2025 Apr 3:dgaf208. doi: 10.1210.
    >> Share

  117. KIM MH, Lee J, Lim DJ, Ishikawa KM, et al
    Thyroid Hormone Sensitivity as a Possible Determinant of Metabolic Phenotypes in Young Adults, Not in the Elderly.
    J Clin Endocrinol Metab. 2025 Apr 3:dgaf214. doi: 10.1210.
    >> Share

  118. KU EJ, Lee J, Yoo WS, Bae J, et al
    Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf213. doi: 10.1210.
    >> Share

  119. DE LEO S, Brigante G, D'Elia S, Censi S, et al
    Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.
    J Clin Endocrinol Metab. 2025 Apr 1:dgaf190. doi: 10.1210.
    >> Share

    March 2025

  120. Correction to: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Mar 27:dgaf185. doi: 10.1210.
    >> Share

  121. SHARIQ OA, Waguespack SG, Hamidi S, Kensing BC, et al
    Approach to the Patient: Hereditary Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2025 Mar 19:dgaf089. doi: 10.1210.
    >> Share


  122. Correction to: "Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules".
    J Clin Endocrinol Metab. 2025 Mar 14:dgaf162. doi: 10.1210.
    >> Share

  123. UWUMIRO F, Arji E, Okpujie V, Asaju F, et al
    National Trends in U.S Hospitalizations and Outcomes of Thyrotoxicosis With and Without Thyrotoxic Storm, 2016-2020.
    J Clin Endocrinol Metab. 2025 Mar 11:dgaf150. doi: 10.1210.
    >> Share

  124. BERGMAN D, Kang X, Sun J, Ebrahimi F, et al
    Autoimmune Thyroid Diseases and Microscopic Colitis: A Nationwide Matched Case-Control Study in Sweden.
    J Clin Endocrinol Metab. 2025 Mar 5:dgaf140. doi: 10.1210.
    >> Share

  125. AEKKA A, Arva NC, Ren HZ, Raval M, et al
    Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the Evaluation of Pediatric Thyroid Nodules.
    J Clin Endocrinol Metab. 2025 Mar 4:dgaf110. doi: 10.1210.
    >> Share

  126. GATTA E, Pirola I, Gotti A, Fredi M, et al
    Clinical phenotype of Graves' disease in Autoimmune Polyglandular Syndrome or as isolated disease: the GRAPHE study.
    J Clin Endocrinol Metab. 2025 Mar 1:dgaf144. doi: 10.1210.
    >> Share

    February 2025
  127. JIA Y, Wang X, Zhang L, Duan Y, et al
    Common and Rare DUOX Variants in Patients with Congenital Hypothyroidism: Case-control Study and Family-based Analysis.
    J Clin Endocrinol Metab. 2025 Feb 24:dgaf109. doi: 10.1210.
    >> Share

  128. SCAPPATICCIO L, Di Martino N, Ferrazzano P, Maiorino MI, et al
    Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-analysis.
    J Clin Endocrinol Metab. 2025 Feb 20:dgaf108. doi: 10.1210.
    >> Share

  129. LAI ST, Bauer AJ
    Approach to the Pediatric Patient with Thyroid Nodules.
    J Clin Endocrinol Metab. 2025 Feb 13:dgaf090. doi: 10.1210.
    >> Share


  130. Correction to: "Associations Between Subclinical Thyroid Dysfunction and Cardiovascular Risk Factors According to Age and Sex".
    J Clin Endocrinol Metab. 2025 Feb 11:dgaf061. doi: 10.1210.
    >> Share

  131. ZHOU J, Li D, Ren J, Huang C, et al
    Machine Learning: A Multicentre Study on Predicting Lateral Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2025 Feb 8:dgaf070. doi: 10.1210.
    >> Share

  132. WANG L, Zhang L, Ma R, Zhang Y, et al
    Semaglutide reprograms macrophages via the GLP-1R/PPARG/ACSL1 pathway to suppress papillary thyroid carcinoma growth.
    J Clin Endocrinol Metab. 2025 Feb 5:dgaf053. doi: 10.1210.
    >> Share

  133. JIANG L, Zhou L, Liu J, Wang Y, et al
    Sex Differences in the Association Between Thyroid Hormone Sensitivity and Cardiovascular-Kidney-Metabolic Syndrome.
    J Clin Endocrinol Metab. 2025 Feb 4:dgaf059. doi: 10.1210.
    >> Share

  134. CIRELLO V, Colombo C, Tosi D, Manzo A, et al
    TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Feb 1:dgaf056. doi: 10.1210.
    >> Share

    January 2025
  135. CHENG KL, Yu WS, Wang YH, Ibarburu GH, et al
    Long-term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2,333,496 Patients from the TriNetX Network.
    J Clin Endocrinol Metab. 2025 Jan 30:dgaf064. doi: 10.1210.
    >> Share

  136. VAN DER MEEREN MMD, Boers T, de Graaf P, Duvivier KM, et al
    Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a learning curve and predictors of success.
    J Clin Endocrinol Metab. 2025 Jan 29:dgaf058. doi: 10.1210.
    >> Share

  137. TELITI M, Chytiris S, Coperchini F, Cerutti M, et al
    The natural history of cytologically low-risk indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2025 Jan 29:dgaf052. doi: 10.1210.
    >> Share

  138. CHOE HJ, Choi YM, Ha Y, Kim J, et al
    The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans.
    J Clin Endocrinol Metab. 2025 Jan 22:dgaf046. doi: 10.1210.
    >> Share

  139. ORTH HM, Killer A, Gliga S, Bohm M, et al
    Subacute thyroiditis - Is it really linked to viral infection? Retrospective hospital patient registry study.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf023. doi: 10.1210.
    >> Share


  140. Correction to: "Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Jan 11:dgae900. doi: 10.1210.
    >> Share

  141. STOUPA A, Kariyawasam D, Jabot-Hanin F, Quoc AN, et al
    Digenic Inheritance Mode in Congenital Hypothyroidism due to Thyroid Dysgenesis: HYPOTYGEN translational cohort study.
    J Clin Endocrinol Metab. 2025 Jan 9:dgaf004. doi: 10.1210.
    >> Share

  142. BARTALENA L, Smith TJ
    Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2025 Jan 9:dgaf009. doi: 10.1210.
    >> Share

  143. ROBENSHTOK E, Bachar G, Ritter A
    Approach to the Patient with Thyroid Cancer: Selection and Management of Candidates for Lobectomy.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae903. doi: 10.1210.
    >> Share

  144. ORSOS I, Molnar Z, Ujhelyi B, Steiber Z, et al
    Stimulation of Piezo1 mechanosensitive channels inhibits adipogenesis in thyroid eye disease.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae899. doi: 10.1210.
    >> Share

    December 2024
  145. PENG R, Xie P, Jin Z, Zhou W, et al
    Significance of Thyroid Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves' Disease.
    J Clin Endocrinol Metab. 2024 Dec 23:dgae892. doi: 10.1210.
    >> Share

  146. HUANG J, Su A, Yang J, Zhuang W, et al
    Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
    J Clin Endocrinol Metab. 2024;110:159-165.
    >> Share

  147. YU B, Wang Y, Jin J, Liu J, et al
    CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae876. doi: 10.1210.
    >> Share

  148. XU Y, Liu R, Huang L, Qin Y, et al
    Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2024 Dec 16:dgae877. doi: 10.1210.
    >> Share

  149. RAZVI SS, Wild H, Ingoe L, Vernazza J, et al
    Changes in thyroid function and autoimmunity in older individuals: longitudinal analysis of the Whickham cohort.
    J Clin Endocrinol Metab. 2024 Dec 14:dgae875. doi: 10.1210.
    >> Share

  150. BARETELLA O, Blum MR, Abolhassani N, Alwan H, et al
    Associations between subclinical thyroid dysfunction and cardiovascular risk factors according to age and sex.
    J Clin Endocrinol Metab. 2024 Dec 12:dgae860. doi: 10.1210.
    >> Share

  151. CHENG Y, Hu H, Li W, Nie S, et al
    Chronic kidney disease and thyroid hormones.
    J Clin Endocrinol Metab. 2024 Dec 9:dgae841. doi: 10.1210.
    >> Share

  152. BEA S, Ahn HY, Woo J, Shin JY, et al
    The Impact of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients.
    J Clin Endocrinol Metab. 2024 Dec 9:dgae858. doi: 10.1210.
    >> Share

  153. GUO Y, Liu B, Liang W, Cheng Y, et al
    2'-O-Galloylhyperin Prevents Tissue Remodeling in Thyroid Eye Disease: Prospects as a Thyrotropin Receptor Antagonist.
    J Clin Endocrinol Metab. 2024 Dec 2:dgae732. doi: 10.1210.
    >> Share

    November 2024
  154. WEI Y, Yang M, Liu J, Wang Y, et al
    Associations between Sensitivity to Thyroid Hormones and Visceral Adiposity in Euthyroid Adults.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae806. doi: 10.1210.
    >> Share

  155. YU X, Liu Y, Wang M, Jia P, et al
    Association between per- and polyfluoroalkyl substance exposures and thyroid homeostasis parameters.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae798. doi: 10.1210.
    >> Share

  156. CHEN Z, Sun W, Fei M, Qian K, et al
    Clinical and Sonographic Differences between RET Fusion-Positive and BRAFV600E in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae803. doi: 10.1210.
    >> Share

  157. SCHUMM MA, Nikiforov YE, Nikiforova MN, Wald AI, et al
    Association of BRAF V600E allele frequency with clinicopathologic outcomes in papillary thyroid cancer.
    J Clin Endocrinol Metab. 2024 Nov 14:dgae774. doi: 10.1210.
    >> Share

  158. SHI B, Liu Z, Zhang R, Tiemuerniyazi X, et al
    Subclinical hypothyroidism as an independent predictor of cardiovascular prognosis in left ventricular thrombus patients.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae793. doi: 10.1210.
    >> Share

  159. WANG H, Li W, Chang P, Jia Q, et al
    Effect of methimazole withdrawl period on the I-131 uptake estimation using Tc-99m thyroid scanning in Graves' disease.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae794. doi: 10.1210.
    >> Share


  160. Correction to: "Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics".
    J Clin Endocrinol Metab. 2024 Nov 1:dgae756. doi: 10.1210.
    >> Share

    October 2024
  161. MENG L, Li H, Fu Y, Yu D, et al
    Somatic DICER1-Mutant Benign Thyroid Nodules in Adults: A Group of Follicular Nodular Disease With Continuous Growth.
    J Clin Endocrinol Metab. 2024 Oct 28:dgae750. doi: 10.1210.
    >> Share

  162. KIM J, Shin J, Kim MS, Moon JH, et al
    Cost-Effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism.
    J Clin Endocrinol Metab. 2024 Oct 24:dgae751. doi: 10.1210.
    >> Share

  163. PARVATHAREDDY SK, Siraj AK, Qadri Z, Siraj N, et al
    The Prognostic Impact of Tumor Size and BRAF Mutational Status in Middle Eastern Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae740. doi: 10.1210.
    >> Share


  164. Correction to: "Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae717. doi: 10.1210.
    >> Share


  165. Correction to: "Effects of Low-dose Methotrexate With Methimazole in Patients With Graves' Disease: Results of a Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae698. doi: 10.1210.
    >> Share

  166. BEHAIRY N, Leonardi AJ, Gubbi S, Kumari S, et al
    Tumor Volume Doubling Time of Less Than One Year is Associated with a Higher Risk of Death from Medullary Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Oct 16:dgae733. doi: 10.1210.
    >> Share

  167. SUN A, Wang X, Qu J, Wu Y, et al
    The efficacy and safety of intravenous tocilizumab to treat Graves' ophthalmopathy: A systematic review and single-arm meta-analysis.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae711. doi: 10.1210.
    >> Share

  168. KELLY CA, Sipos JA
    Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae722. doi: 10.1210.
    >> Share

  169. LEE S, Antunez AG, Sinco B, Saucke MC, et al
    Cancer-related Fear and Worry in Patients with Low-Risk Thyroid Cancer: A Longitudinal Cohort Study.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae688. doi: 10.1210.
    >> Share

  170. PHAM-DOBOR G, Kaltenecker P, Temesfoi V, Bajnok L, et al
    Systematic analysis and network mapping of disease associations in autoimmune polyglandular syndrome.
    J Clin Endocrinol Metab. 2024 Oct 8:dgae701. doi: 10.1210.
    >> Share

  171. NISHIHARA E, Fukata S, Hirokawa M, Higuchi M, et al
    Nodule-specific NRF2-targeted upregulation in patients with KEAP1 mutations and familial nontoxic multinodular goiter.
    J Clin Endocrinol Metab. 2024 Oct 7:dgae699. doi: 10.1210.
    >> Share

  172. HSU YC, Kuo CY, Chien MN, Jhuang JY, et al
    Overexpression of NR1D1 portends disease recurrence in thyroid cancer.
    J Clin Endocrinol Metab. 2024 Oct 3:dgae687. doi: 10.1210.
    >> Share

  173. MEHANNA H, Nankivell P, Boelaert K, Woolley R, et al
    Diagnostic performance of ultrasound vs. ultrasound-guided FNAc in thyroid nodules: data from the ElaTION trial.
    J Clin Endocrinol Metab. 2024 Oct 3:dgae682. doi: 10.1210.
    >> Share

  174. ROTONDI M, Endo M, Teliti M, Crescenzi A, et al
    Beyond malignancy risk stratification: FNAC report anticipates thyroid cancer staging. Insights from recent studies.
    J Clin Endocrinol Metab. 2024 Oct 1:dgae675. doi: 10.1210.
    >> Share

    September 2024
  175. MULDER TA, Guxens M, Rebagliato ML, Dineva M, et al
    Association of maternal thyroglobulin with gestational thyroid function and offspring IQ and brain morphology.
    J Clin Endocrinol Metab. 2024 Sep 27:dgae679. doi: 10.1210.
    >> Share

  176. MORETTI S, Mandarano M, Menicali E, Guzzetti M, et al
    Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer.
    J Clin Endocrinol Metab. 2024 Sep 27:dgae667. doi: 10.1210.
    >> Share

  177. XU B, Baine MK, Jungbluth A, Alabkaa A, et al
    Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Sep 26:dgae672. doi: 10.1210.
    >> Share

  178. ROBENSHTOK E
    Selective Use of Radioiodine in Pediatric Thyroid Cancer - A Paradigm Shift.
    J Clin Endocrinol Metab. 2024 Sep 21:dgae656. doi: 10.1210.
    >> Share

  179. ZHANG Y, Zhang X, Lin L, Xing M, et al
    Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer: a meta-analysis.
    J Clin Endocrinol Metab. 2024 Sep 18:dgae617. doi: 10.1210.
    >> Share

  180. MACIEL AAW, Danilovic DLS, Soares IC, Freitas TC, et al
    Association between papillary thyroid cancer and primary aldosteronism in individuals with hypertension.
    J Clin Endocrinol Metab. 2024 Sep 18:dgae653. doi: 10.1210.
    >> Share

  181. DE LIMA BELTRAO FE, Carvalhal G, de Almeida Beltrao DC, de Lima Beltrao FE, et al
    Treatment Preferences in Patients with Hypothyroidism: an Analysis of Eleven Randomized Controlled Trials.
    J Clin Endocrinol Metab. 2024 Sep 18:dgae651. doi: 10.1210.
    >> Share

  182. FENG J, Xu X, Cai W, Yang X, et al
    Inhibiting Soluble Epoxide Hydrolase Suppresses NF-kappaB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis.
    J Clin Endocrinol Metab. 2024;109:2579-2588.
    >> Share

  183. REICH T, Bakirov R, Budka D, Kelly D, et al
    Data-Driven Strategies for Carbimazole Titration: Exploring Machine Learning Solutions in Hyperthyroidism Control.
    J Clin Endocrinol Metab. 2024 Sep 13:dgae642. doi: 10.1210.
    >> Share

  184. XU L, Liu Z, Xu X, Wan Q, et al
    Thyroid autoimmunity is associated with dietary fat consumption.
    J Clin Endocrinol Metab. 2024 Sep 12:dgae629. doi: 10.1210.
    >> Share

  185. SPONA DC, Frodi DM, Xing LY, Kongebro EK, et al
    Effects of atrial fibrillation screening according to thyroid function: Post-hoc analysis of the randomized LOOP study.
    J Clin Endocrinol Metab. 2024 Sep 4:dgae610. doi: 10.1210.
    >> Share

  186. YAN Y, Chu X, Wang J, Kang X, et al
    Alterations in Thyroid Hormones in Obese Patients are Associated with Body Composition Changes after Bariatric Surgery.
    J Clin Endocrinol Metab. 2024 Sep 2:dgae605. doi: 10.1210.
    >> Share

    August 2024
  187. YUAN J, Chen Z, Zhang J, Chen X, et al
    Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Papillary Thyroid Cancer Patients.
    J Clin Endocrinol Metab. 2024 Aug 30:dgae601. doi: 10.1210.
    >> Share

  188. MOOIJ CF, Zwaveling-Soonawala N, Hillebrand JJ, van Trotsenburg ASP, et al
    Approach to the Patient: Challenging Cases of Pediatric Thyrotoxicosis.
    J Clin Endocrinol Metab. 2024 Aug 27:dgae592. doi: 10.1210.
    >> Share

  189. XU Y, Gao J, Wang N, Zedenius J, et al
    BRAF-induced EHF expression affects TERT in aggressive papillary thyroid cancer.
    J Clin Endocrinol Metab. 2024 Aug 24:dgae589. doi: 10.1210.
    >> Share

  190. RAMONE T, Ghirri A, Prete A, Matrone A, et al
    Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance.
    J Clin Endocrinol Metab. 2024 Aug 24:dgae575. doi: 10.1210.
    >> Share

  191. STEGENGA MT, Oudijk L, van Velsen EFS, Peeters RP, et al
    Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.
    J Clin Endocrinol Metab. 2024 Aug 21:dgae581. doi: 10.1210.
    >> Share

  192. CASTELLANOS LE, Zafereo ME, Sturgis EM, Wang JR, et al
    Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine.
    J Clin Endocrinol Metab. 2024 Aug 20:dgae576. doi: 10.1210.
    >> Share

  193. GRANI G, D'Elia S, Puxeddu E, Morelli S, et al
    Data-Driven Thyroglobulin Cutoffs for Low- and Intermediate-Risk Thyroid Cancer Follow-Up: ITCO Real-World Analysis.
    J Clin Endocrinol Metab. 2024 Aug 16:dgae559. doi: 10.1210.
    >> Share

  194. SMITH TJ, Holt RJ, Fu Q, Qashqai A, et al
    Assessment of hearing dysfunction in patients with Graves' disease and thyroid eye disease without or with teprotumumab.
    J Clin Endocrinol Metab. 2024 Aug 14:dgae560. doi: 10.1210.
    >> Share

  195. IYER PC, Dadu R, Barque A, Zanelli C, et al
    Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay.
    J Clin Endocrinol Metab. 2024;109:2269-2273.
    >> Share

  196. LI G, Ye Z, Wei T, Zhu J, et al
    Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
    J Clin Endocrinol Metab. 2024;109:2294-2305.
    >> Share

  197. ENDO M, Peng J, Nabhan FA, Brock P, et al
    Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.
    J Clin Endocrinol Metab. 2024;109:2317-2324.
    >> Share

  198. KONDA B, Sherman EJ, Massarelli E, Nieva J, et al
    Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2024 Aug 12:dgae512. doi: 10.1210.
    >> Share

  199. REINKE R, Udholm S, Christiansen CF, Almquist M, et al
    Increased risk of chronic kidney disease after total thyroidectomy: A nationwide matched cohort study.
    J Clin Endocrinol Metab. 2024 Aug 10:dgae534. doi: 10.1210.
    >> Share

  200. DUNTAS LH, Zarkovic M
    A small opening in the storm clouds: overview of the registry-based study on the management of thyroid storm.
    J Clin Endocrinol Metab. 2024 Aug 9:dgae543. doi: 10.1210.
    >> Share

  201. GHOSH R, Auh S, Gubbi S, Veeraraghavan P, et al
    Association of Free Thyroxine with Progression-Free Survival in Intermediate and High Risk Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Aug 8:dgae537. doi: 10.1210.
    >> Share

  202. WANG JR, Zafereo ME, Cabanillas ME, Wu CC, et al
    The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Aug 1:dgae532. doi: 10.1210.
    >> Share

    July 2024
  203. OSINGA JAJ, Nelson SM, Walsh JP, Ashoor G, et al
    Defining gestational thyroid dysfunction through modified non-pregnancy reference intervals: an individual participant meta-analysis.
    J Clin Endocrinol Metab. 2024 Jul 31:dgae528. doi: 10.1210.
    >> Share

  204. ALVES JUNIOR JM, Bernardo W, Villagelin D
    "Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review with Meta-analysis".
    J Clin Endocrinol Metab. 2024 Jul 30:dgae526. doi: 10.1210.
    >> Share

  205. SINKO R, Katko M, Toth G, Kovacs GL, et al
    Novel biomarkers reveal mismatch between tissue and serum thyroid hormone status in amiodarone-induced hyperthyroidism.
    J Clin Endocrinol Metab. 2024 Jul 30:dgae514. doi: 10.1210.
    >> Share

  206. FENG J, Wu C, Shen F, Cai W, et al
    Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis.
    J Clin Endocrinol Metab. 2024 Jul 24:dgae501. doi: 10.1210.
    >> Share

  207. LUPO MA, Olivo PD, Luffy M, Wolf J, et al
    US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease.
    J Clin Endocrinol Metab. 2024 Jul 19:dgae448. doi: 10.1210.
    >> Share

  208. GERMAN A, Almashanu S, de Vries L, Gil Margolis M, et al
    Insights into Central Congenital Hypothyroidism: A Multicenter Retrospective Analysis.
    J Clin Endocrinol Metab. 2024 Jul 15:dgae485. doi: 10.1210.
    >> Share

  209. ZHOU J, Chen W, Jiang WH, Wu Q, et al
    Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy.
    J Clin Endocrinol Metab. 2024;109:2071-2082.
    >> Share

  210. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
    Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
    >> Share

  211. XIE P, Shen L, Peng R, Wang Y, et al
    Effects of low-dose methotrexate with MMI in patients with Graves' disease: results of a randomized clinical trial.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae472. doi: 10.1210.
    >> Share

  212. PIGNATA L, Bagattini B, Di Cosmo C, Agretti P, et al
    Clinical course of congenital hypothyroidism with gland in situ and necessity of L-thyroxine therapy after re-evaluation.
    J Clin Endocrinol Metab. 2024 Jul 10:dgae471. doi: 10.1210.
    >> Share

  213. AHMADI S, Sipos JA
    Cost-effectiveness of molecular testing for thyroid nodules with indeterminate cytology.
    J Clin Endocrinol Metab. 2024 Jul 10:dgae470. doi: 10.1210.
    >> Share

  214. WANG H, Li Q, Tian T, Liu B, et al
    Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Jul 9:dgae465. doi: 10.1210.
    >> Share

  215. AZIZI F, Mehran L, Abdi H, Amouzegar A, et al
    Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2024 Jul 9:dgae456. doi: 10.1210.
    >> Share

  216. ROVET JF
    Targeting the Manifestations of Subclinical and Overt Hypothyroidism Within the Hippocampus.
    J Clin Endocrinol Metab. 2024 Jul 6:dgae453. doi: 10.1210.
    >> Share

  217. JING R, Wu N, Wu Y, Zhang Q, et al
    Efficacy and safety of multikinase inhibitors for patients with refractory thyroid cancer: Systematic review and network meta-analysis.
    J Clin Endocrinol Metab. 2024 Jul 6:dgae454. doi: 10.1210.
    >> Share

  218. ZHAI X, Li Y, Teng X, Teng W, et al
    Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older Adults.
    J Clin Endocrinol Metab. 2024 Jul 2:dgae387. doi: 10.1210.
    >> Share


  219. Correction to: "TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma".
    J Clin Endocrinol Metab. 2024 Jul 1:dgae442. doi: 10.1210.
    >> Share

    June 2024
  220. SEHGAL K, Serritella A, Liu M, ONeill A, et al
    A phase I/II trial of sapanisertib in advanced anaplastic and radioiodine refractory differentiated thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Jun 29:dgae443. doi: 10.1210.
    >> Share

  221. PARDI E, Poma AM, Torregrossa L, Pierotti L, et al
    Whole-exome sequencing of atypical parathyroid tumors detects novel and common genes linked to parathyroid tumorigenesis.
    J Clin Endocrinol Metab. 2024 Jun 28:dgae441. doi: 10.1210.
    >> Share

  222. WILLIAMS MD, Liu Z, Rossi ED, Agarwal S, et al
    Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents.
    J Clin Endocrinol Metab. 2024 Jun 14:dgae354. doi: 10.1210.
    >> Share

    May 2024
  223. CAO H, Shangguan L, Zhu H, Hu C, et al
    Prognostic analysis of 131I efficacy after papillary thyroid carcinoma surgery based on CT radiomics.
    J Clin Endocrinol Metab. 2024 May 27:dgae364. doi: 10.1210.
    >> Share

  224. MOLLEHAVE LT, Grand MK, Kriegbaum M, Andersen CL, et al
    Maternal thyroid function in early pregnancy and offspring school performance and neurodevelopmental disorders.
    J Clin Endocrinol Metab. 2024 May 24:dgae358. doi: 10.1210.
    >> Share

  225. SCHREINER F, Vollbach H, Sonntag N, Schempp V, et al
    Phenylbutyrate Treatment in a Boy with MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Livertoxicity.
    J Clin Endocrinol Metab. 2024 May 24:dgae356. doi: 10.1210.
    >> Share

  226. ETTLESON MD, Penna GCE, Wan W, Bensenor IM, et al
    TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort.
    J Clin Endocrinol Metab. 2024 May 23:dgae294. doi: 10.1210.
    >> Share

  227. LEVESQUE F, Payne RJ, Beaudoin D, Boucher A, et al
    A Prospective Study of Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada's Experience.
    J Clin Endocrinol Metab. 2024 May 23:dgae355. doi: 10.1210.
    >> Share

  228. GRANI G
    The pathologist counts-so many variables in the risk stratification of thyroid cancers.
    J Clin Endocrinol Metab. 2024 May 22:dgae360. doi: 10.1210.
    >> Share

  229. LI G, Chen W, Jiang K, Huang J, et al
    Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC.
    J Clin Endocrinol Metab. 2024;109:1601-1617.
    >> Share

  230. CONOVER CA, Bale LK, Stan MN
    PAPP-A as a Potential Target in Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2024 May 16:dgae339. doi: 10.1210.
    >> Share

  231. XIAN K, Xu S, Huang H, Xing C, et al
    Synergy of nodal factors in predicting recurrence after treatment of N1b papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 May 15:dgae329. doi: 10.1210.
    >> Share

  232. SCHOLZ A, McNabb CB, Bloomfield L, Bhargava R, et al
    Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on adolescent brain morphology.
    J Clin Endocrinol Metab. 2024 May 15:dgae338. doi: 10.1210.
    >> Share

  233. ZHANG W, Lin S, Wang Z, Zhang W, et al
    Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targets in Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 May 13:dgae327. doi: 10.1210.
    >> Share

  234. SOHN SY, Inoue K, Bashir MT, Currier JW, et al
    Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis.
    J Clin Endocrinol Metab. 2024 May 3:dgae304. doi: 10.1210.
    >> Share

    April 2024
  235. PETROVIC I, LoPresti J, Fatemi S, Gianoukakis A, et al
    Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA).
    J Clin Endocrinol Metab. 2024 Apr 30:dgae286. doi: 10.1210.
    >> Share

  236. SANT VR, Radhachandran A, Ivezic V, Lee DT, et al
    From Bench-to-Bedside: How Artificial Intelligence Is Changing Thyroid Nodule Diagnostics.
    J Clin Endocrinol Metab. 2024 Apr 29:dgae277. doi: 10.1210.
    >> Share

  237. SUN F, Zhang RJ, Fang Y, Yan CY, et al
    Identification of Eukaryotic Translation Initiation Factor 4B as a Novel Candidate Gene for Congenital Hypothyroidism.
    J Clin Endocrinol Metab. 2024 Apr 24:dgae270. doi: 10.1210.
    >> Share

  238. ABOU AZAR S, Tobias J, Applewhite M, Angelos P, et al
    Medullary Thyroid Cancer: Single Institute Experience over Three Decades and Risk Factors for Recurrence.
    J Clin Endocrinol Metab. 2024 Apr 23:dgae279. doi: 10.1210.
    >> Share

  239. CHO YY, Ahn SH, Lee EK, Park YJ, et al
    Malignancy Risk of Follicular Neoplasm (Bethesda IV) With Variable Cutoffs of Tumor Size: A Systemic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2024;109:1383-1392.
    >> Share

  240. TODA S, Hiroshima Y, Iwasaki H, Masudo K, et al
    Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
    J Clin Endocrinol Metab. 2024 Apr 17:dgae271. doi: 10.1210.
    >> Share

  241. LEE J, Baek HS, Jo K, Kim MH, et al
    The Impact of Physical Activity on Thyroid Health: Insights From Representative Data in Korea.
    J Clin Endocrinol Metab. 2024 Apr 15:dgae178. doi: 10.1210.
    >> Share

  242. BAEK HS, Kim J, Jeong C, Lee J, et al
    Deep Learning Analysis with Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.
    J Clin Endocrinol Metab. 2024 Apr 13:dgae254. doi: 10.1210.
    >> Share

  243. GUO S, Li R, Li G, Chen W, et al
    Comparing ChatGPT's and surgeon's responses to thyroid-related questions from patients.
    J Clin Endocrinol Metab. 2024 Apr 10:dgae235. doi: 10.1210.
    >> Share

  244. PERROS P, Nagy EV, Papini E, Abad-Madronero J, et al
    Hypothyroidism and Type D Personality: Results From E-MPATHY, a Cross-sectional International Online Patient Survey.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae140. doi: 10.1210.
    >> Share

  245. HUANG PS, Tsai CT
    Response to Letter to the Editor From Sukor and Kamaruddin: "Higher Risk of Incident Hyperthyroidism in Patients with Atrial Fibrillation".
    J Clin Endocrinol Metab. 2024 Apr 8:dgae190. doi: 10.1210.
    >> Share

  246. VILLAGELIN D, Cooper DS, Burch HB
    A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
    >> Share

  247. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
    TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
    >> Share

  248. NEWMAN SK, Tuttle RM
    Redefining actionable disease in well differentiated thyroid cancer management.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae218. doi: 10.1210.
    >> Share

  249. LIU CQ, Shen CK, Du YX, Li ZM, et al
    Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer.
    J Clin Endocrinol Metab. 2024 Apr 4:dgae214. doi: 10.1210.
    >> Share

    March 2024
  250. LEE-SAXTON YJ, Egan CE, Bratton BA, Thiesmeyer JW, et al
    Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence.
    J Clin Endocrinol Metab. 2024 Mar 30:dgae203. doi: 10.1210.
    >> Share

  251. MATSUO Y, Miyawaki A, Watanabe H, Matsui H, et al
    Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study.
    J Clin Endocrinol Metab. 2024 Mar 28:dgae187. doi: 10.1210.
    >> Share

  252. SUKOR N, Kamaruddin NA
    Letter to the Editor from Sukor and Kamaruddin "Higher Risk of Incident Hyperthyroidism in Patients with Atrial Fibrillation".
    J Clin Endocrinol Metab. 2024 Mar 27:dgae189. doi: 10.1210.
    >> Share

  253. HIRTZ R, Thamm R, Kuhnert R, Liesenkotter KP, et al
    New Reference Values for Thyroid Volume by Ultrasound in German Children and Adolescents from a Population-Based Study.
    J Clin Endocrinol Metab. 2024 Mar 26:dgae194. doi: 10.1210.
    >> Share


  254. Correction to: "Structural and Functional Alterations of Hippocampal Subfields in Patients With Adult-Onset Primary Hypothyroidism".
    J Clin Endocrinol Metab. 2024 Mar 20:dgae159. doi: 10.1210.
    >> Share

  255. PENNA GC, Bensenor IM, Bianco AC, Ettleson MD, et al
    Thyroid hormone homeostasis in levothyroxine-treated patients: Findings from ELSA-Brasil.
    J Clin Endocrinol Metab. 2024 Mar 20:dgae139. doi: 10.1210.
    >> Share

  256. MAROTTA V, Rocco D, Crocco A, Deiana MG, et al
    Survival predictors of radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the real-life.
    J Clin Endocrinol Metab. 2024 Mar 19:dgae181. doi: 10.1210.
    >> Share


  257. Correction to: "The Cross-sectional and Longitudinal Association Between Thyroid Function and Depression: A Population-Based Study".
    J Clin Endocrinol Metab. 2024 Mar 14:dgae148. doi: 10.1210.
    >> Share

  258. OHIRA T, Nagao M, Hayashi F, Shimura H, et al
    Effects of Overweight on Risk of Thyroid Nodules in Children and Adolescents: The Fukushima Health Management Survey.
    J Clin Endocrinol Metab. 2024 Mar 13:dgae161. doi: 10.1210.
    >> Share

  259. FURUKAWA Y, Tanaka K, Isozaki O, Suzuki A, et al
    Prospective Multicenter Registry-Based Study on Thyroid Storm: The Guidelines for the Management from Japan are Useful.
    J Clin Endocrinol Metab. 2024 Mar 8:dgae124. doi: 10.1210.
    >> Share

  260. DAYAN CM
    The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).
    J Clin Endocrinol Metab. 2024 Mar 7:dgad693. doi: 10.1210.
    >> Share

  261. CHEN H, Liu Y, Wang F, Sun J, et al
    MeIS: DNA methylation-based immune response signatures for thyroid nodule diagnostics.
    J Clin Endocrinol Metab. 2024 Mar 7:dgae141. doi: 10.1210.
    >> Share

  262. HENSLEY SG, Hu MI, Bassett RL, Ying AK, et al
    Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades.
    J Clin Endocrinol Metab. 2024 Mar 4:dgae133. doi: 10.1210.
    >> Share

    February 2024
  263. SARKAR R, Bolel P, Kapoor A, Eliseeva E, et al
    An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers.
    J Clin Endocrinol Metab. 2024 Feb 29:dgae114. doi: 10.1210.
    >> Share

  264. LACLAUSTRA M, Alonso-Ventura V, Schipf S, Lou-Bonafonte JM, et al
    Higher Parametric Thyroid Feedback Quantile-based Index is a predictor of type 2 diabetes in a German population sample.
    J Clin Endocrinol Metab. 2024 Feb 29:dgae110. doi: 10.1210.
    >> Share

  265. JAGANNATH S, Mayilvaganan S
    Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma".
    J Clin Endocrinol Metab. 2024 Feb 29:dgae117. doi: 10.1210.
    >> Share

  266. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Response to Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?".
    J Clin Endocrinol Metab. 2024 Feb 28:dgae118. doi: 10.1210.
    >> Share

  267. AHMADI S, Kotwal A, Bikas A, Xiang P, et al
    Outcomes of cytologically indeterminate thyroid nodules managed with Genomic Sequencing Classifier.
    J Clin Endocrinol Metab. 2024 Feb 28:dgae112. doi: 10.1210.
    >> Share

  268. VAN DER TUIN K, Ruano D, Knijnenburg J, van der Luijt RB, et al
    Clinically-relevant Germline Variants in Children with Non-Medullary Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Feb 28:dgae107. doi: 10.1210.
    >> Share

  269. MAINO F, Botte M, Dalmiglio C, Valerio L, et al
    Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
    J Clin Endocrinol Metab. 2024;109:722-729.
    >> Share

  270. TANASE-NAKAO K, Iwahashi-Odano M, Sugisawa C, Abe K, et al
    Genotype-Phenotype Correlations in Thirty Japanese Patients with Congenital Hypothyroidism Attributable to TG Defects.
    J Clin Endocrinol Metab. 2024 Feb 19:dgae098. doi: 10.1210.
    >> Share

  271. ALTSHULER B, Bikas A, Pappa T, Marqusee E, et al
    Non-Operative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.
    J Clin Endocrinol Metab. 2024 Feb 13:dgae082. doi: 10.1210.
    >> Share

  272. STEGENGA MT, van Velsen EFS, Oudijk L, Verburg FA, et al
    Clinical and Histopathological Risk Factors for Radioactive Iodine Refractory Follicular and Oncocytic Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2024 Feb 13:dgae084. doi: 10.1210.
    >> Share


  273. Correction to: "Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination".
    J Clin Endocrinol Metab. 2024 Feb 8:dgae064. doi: 10.1210.
    >> Share


  274. Correction to: "Nodal Metastases Associated With Fusion Oncogenes Are Age Dependent in Young Adult Patients With Thyroid Cancer".
    J Clin Endocrinol Metab. 2024 Feb 7:dgae065. doi: 10.1210.
    >> Share

  275. ZHANG T, Zhao L, Chen C, Yang C, et al
    Structural and Functional Alterations of Hippocampal Subfields in Patients with Adult-onset Primary Hypothyroidism.
    J Clin Endocrinol Metab. 2024 Feb 7:dgae070. doi: 10.1210.
    >> Share

    January 2024
  276. DOSIOU C
    "Teprotumumab for inactive thyroid eye disease? The jury is still out.".
    J Clin Endocrinol Metab. 2024 Jan 27:dgae052. doi: 10.1210.
    >> Share

  277. WANG H, Peng Y, Xia X, Jiang Y, et al
    Effect of thyroid function on offspring neurodevelopment in people receiving ART therapy: a prospective cohort study.
    J Clin Endocrinol Metab. 2024 Jan 24:dgae046. doi: 10.1210.
    >> Share

  278. LOPES-PEREIRA M, Roque S, Machado SI, Korevaar TIM, et al
    Iodineminho Study: Iodine Supplementation and Prevalence of Iodine Deficiency in Pregnant Women.
    J Clin Endocrinol Metab. 2024 Jan 24:dgae041. doi: 10.1210.
    >> Share

  279. CONDELLO V, Poma AM, Macerola E, Vignali P, et al
    Prevalence, Molecular Landscape and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.
    J Clin Endocrinol Metab. 2024 Jan 22:dgae034. doi: 10.1210.
    >> Share

  280. DE ANGELIS S, Medda E, Rotondi D, Masocco M, et al
    Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019).
    J Clin Endocrinol Metab. 2024;109:e495-e507.
    >> Share

  281. JENSEN CZ, Isaksen JL, Ahlberg G, Olesen MS, et al
    Association of DIO2 and MCT10 Polymorphisms With Persistent Symptoms in LT4-Treated Patients in the UK Biobank.
    J Clin Endocrinol Metab. 2024;109:e613-e622.
    >> Share

  282. LUDAR H, Levy-Shraga Y, Admoni O, Majdoub H, et al
    Clinical and Molecular Characteristics and Long-term Follow-up of Children With Pseudohypoparathyroidism Type IA.
    J Clin Endocrinol Metab. 2024;109:424-438.
    >> Share

  283. BHARADWAJ MS, Ballal S, Bal C
    Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.
    J Clin Endocrinol Metab. 2024 Jan 12:dgae024. doi: 10.1210.
    >> Share

  284. BARASCH E, Gottdiener J, Buzkova P, Cappola A, et al
    Association of thyroid dysfunction in individuals >/= 65 years of age with subclinical cardiac abnormalities.
    J Clin Endocrinol Metab. 2024 Jan 6:dgae001. doi: 10.1210.
    >> Share

  285. BUCZYNSKA A, Kosciuszko M, Sidorkiewicz I, Wiatr AA, et al
    Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer via a Biomarker Panel Involving TAC, 8-OHdG and Sortilin.
    J Clin Endocrinol Metab. 2024 Jan 5:dgae007. doi: 10.1210.
    >> Share


  286. Correction to: "Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review".
    J Clin Endocrinol Metab. 2024 Jan 3:dgad759. doi: 10.1210.
    >> Share

    December 2023
  287. KIM BH, Ryu SR, Lee JW, Song CM, et al
    Longitudinal changes in quality of life before and after thyroidectomy in patients with differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2023 Dec 23:dgad748. doi: 10.1210.
    >> Share

  288. WEN X, Chang X, He X, Cai Q, et al
    Increased Thyroid DPP4 Expression is Associated with Inflammatory Process in Patients with Hashimoto's Thyroiditis.
    J Clin Endocrinol Metab. 2023 Dec 21:dgad723. doi: 10.1210.
    >> Share

  289. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
    Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
    J Clin Endocrinol Metab. 2023;109:e347-e355.
    >> Share

  290. GOLDNER W
    The Role of Age in the Risk Assessment of Differentiated Thyroid Cancers.
    J Clin Endocrinol Metab. 2023 Dec 20:dgad743. doi: 10.1210.
    >> Share

  291. DING X, Liu Z, Zhang B, Yang Y, et al
    Permanent versus Transient Congenital Hypothyroidism in Chinese Children: Physical Growth and Predictive Nomogram.
    J Clin Endocrinol Metab. 2023 Dec 16:dgad739. doi: 10.1210.
    >> Share

  292. QIN Z, Muhanhali D, Ling Y
    Impaired thyroid hormone sensitivity increases risk of cardiovascular events in patients undergoing coronary angiography.
    J Clin Endocrinol Metab. 2023 Dec 16:dgad735. doi: 10.1210.
    >> Share

  293. LIN S, Wang Z, Xing M
    Association between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
    J Clin Endocrinol Metab. 2023 Dec 8:dgad722. doi: 10.1210.
    >> Share

  294. MU Z, Zhang X, Sun D, Sun Y, et al
    Characterizing genetic alterations related to radioiodine avidity in metastatic thyroid cancer.
    J Clin Endocrinol Metab. 2023 Dec 7:dgad697. doi: 10.1210.
    >> Share

  295. CHEN DW, Singh Ospina N, Haymart MR
    Social Determinants of Health and Disparities in Thyroid Care.
    J Clin Endocrinol Metab. 2023 Dec 6:dgad716. doi: 10.1210.
    >> Share

  296. LEUNG AM, Brent GA
    Pregnancy - Does Promotion of Growth Extend to Thyroid Cancer?
    J Clin Endocrinol Metab. 2023 Dec 2:dgad707. doi: 10.1210.
    >> Share

  297. WANG Y, Zou B, Zhang Y, Zhang J, et al
    Comprehensive long-read sequencing analysis discloses the transcriptome features of Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Dec 1:dgad695. doi: 10.1210.
    >> Share

    November 2023
  298. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Role of the degree of vascular invasion in predicting prognosis of follicular thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Nov 25:dgad689. doi: 10.1210.
    >> Share


  299. Correction to: "Critical Approach to Hypothyroid Patients With Persistent Symptoms".
    J Clin Endocrinol Metab. 2023 Nov 23:dgad678. doi: 10.1210.
    >> Share

  300. MORAN C, Schoenmakers N, Halsall D, Oddy S, et al
    Approach to the patient with raised thyroid hormones and non-suppressed TSH.
    J Clin Endocrinol Metab. 2023 Nov 21:dgad681. doi: 10.1210.
    >> Share

  301. LIU Q, Mao L, Zhang Z, Li G, et al
    Diagnostic Efficacy of FNA-Tg in DTC Cervical LN Metastasis and its Impact Factors: A Large Retrospective Study.
    J Clin Endocrinol Metab. 2023;108:3311-3319.
    >> Share

  302. STRICH D, Israel A, Edri S, Gillis D, et al
    Age and Gender Adjusted FT3 Levels as Novel Predictors of Survival.
    J Clin Endocrinol Metab. 2023;108:3295-3301.
    >> Share

  303. LI P, Liu Y, Wei T, Wang X, et al
    Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
    J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
    >> Share

  304. LAFONTAINE N, Shore CJ, Campbell PJ, Mullin BH, et al
    Epigenome-wide association study shows differential DNA methylation of MDC1, KLF9 and CUTA in autoimmune thyroid disease.
    J Clin Endocrinol Metab. 2023 Nov 14:dgad659. doi: 10.1210.
    >> Share

    October 2023
  305. KWON H, Han KD, Moon SJ, Park SE, et al
    Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
    >> Share

  306. DOUGLAS RS, Couch S, Wester ST, Fowler BT, et al
    Efficacy and Safety of Teprotumumab in Thyroid Eye Disease Patients with Long Duration and Low Disease Activity.
    J Clin Endocrinol Metab. 2023 Oct 31:dgad637. doi: 10.1210.
    >> Share

  307. NEMIROFF S, Chai R, Fan J, Ramer-Bass I, et al
    Ectopic Cervical Thymoma in a Patient Diagnosed with Graves Disease: A Systematic Literature Review.
    J Clin Endocrinol Metab. 2023 Oct 28:dgad635. doi: 10.1210.
    >> Share

  308. MORRIS EJ, Vouri SM, Maraka S, Singh Ospina N, et al
    Trends and components of thyroid status evaluation in commercially insured adults in the US, 2006-2020.
    J Clin Endocrinol Metab. 2023 Oct 27:dgad632. doi: 10.1210.
    >> Share

  309. PENNA GC, Bianco AC, Ettleson MD
    A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone.
    J Clin Endocrinol Metab. 2023 Oct 25:dgad629. doi: 10.1210.
    >> Share

  310. WU Q, Zhou J, Fang W, Jiang WH, et al
    Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
    J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
    >> Share

  311. VAN DER SPOEL E, van Vliet NA, Poortvliet RKE, Du Puy RS, et al
    Incidence and determinants of spontaneous normalization of subclinical hypothyroidism in older adults.
    J Clin Endocrinol Metab. 2023 Oct 20:dgad623. doi: 10.1210.
    >> Share

  312. ROA DUENAS OH, Hofman A, Luik AI, Medici M, et al
    The Cross-sectional and Longitudinal Association Between Thyroid Function and Depression: A Population-Based Study.
    J Clin Endocrinol Metab. 2023 Oct 19:dgad620. doi: 10.1210.
    >> Share

  313. LUI DTW, Wong CKH, Man KKC
    Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.
    >> Share

  314. MULLER I, Consonni D, Crivicich E, di Marco F, et al
    Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
    J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.
    >> Share

  315. LI Y, Sun J, Jiao Y, Li N, et al
    Impaired sensitivity to thyroid hormones is associated with decreased vitamin D levels in the euthyroid population.
    J Clin Endocrinol Metab. 2023 Oct 13:dgad607. doi: 10.1210.
    >> Share


  316. Correction to "Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study".
    J Clin Endocrinol Metab. 2023 Oct 11:dgad596. doi: 10.1210.
    >> Share

  317. GORSHTEIN A, Turjeman A, Duskin-Bitan H, Leibovici L, et al
    Graves' disease following COVID-19 vaccination: a population-based, matched case-control study.
    J Clin Endocrinol Metab. 2023 Oct 10:dgad582. doi: 10.1210.
    >> Share

  318. DAI P, Zhao W, Zheng X, Luo H, et al
    Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant.
    J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
    >> Share

  319. ESFANDIARI NH, Papaleontiou M
    Levothyroxine Prescribing: Why Simple is so Complex.
    J Clin Endocrinol Metab. 2023 Oct 4:dgad585. doi: 10.1210.
    >> Share

  320. ZHANG S, Zhao X, Wang X, Jin H, et al
    Gut microecology may be involved in pathogenesis of Hashimoto's thyroiditis by reducing production of hydrogen sulfide.
    J Clin Endocrinol Metab. 2023 Oct 4:dgad588. doi: 10.1210.
    >> Share


  321. Correction to "The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation".
    J Clin Endocrinol Metab. 2023 Oct 3:dgad573. doi: 10.1210.
    >> Share

    September 2023
  322. PALYGA I, Rumian M, Kosel A, Albrzykowski M, et al
    The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy.
    J Clin Endocrinol Metab. 2023 Sep 28:dgad571. doi: 10.1210.
    >> Share

  323. NAESSEN S, Eliasson M, Berntorp K, Kitlinski M, et al
    Autoimmune disease in Turner syndrome in Sweden: An up to 25 years controlled follow-up study.
    J Clin Endocrinol Metab. 2023 Sep 27:dgad566. doi: 10.1210.
    >> Share

  324. MELING STOKLAND AE, Austdal M, Nedrebo BG, Carlsen S, et al
    Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
    J Clin Endocrinol Metab. 2023 Sep 25:dgad538. doi: 10.1210.
    >> Share

  325. OSINGA JAJ, Derakhshan A, Feldt-Rasmussen U, Huang K, et al
    TSH and FT4 reference interval recommendations and prevalence of gestational thyroid dysfunction: quantification of current diagnostic approaches.
    J Clin Endocrinol Metab. 2023 Sep 22:dgad564. doi: 10.1210.
    >> Share

  326. XIAO WC, Li X, Shan R, Mei F, et al
    Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
    >> Share

  327. ZHANG X, Wang Y, Wang H, Zhang X, et al
    Trends in Prevalence of Thyroid Dysfunction and its Associations with Mortality Among US Participants, 1988-2012.
    J Clin Endocrinol Metab. 2023 Sep 20:dgad558. doi: 10.1210.
    >> Share

  328. WANG M, Jiang X, Geng J, Hui S, et al
    Outcomes of Patients With Dysthyroid Optic Neuropathy Treated With Intravenous Corticosteroids and/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2023;108:2717-2727.
    >> Share

  329. DE MORAIS NS, Leung AM
    Maternal Thyroid Function: Does it Have a Role in Fetal Programming and Later Offspring Growth?
    J Clin Endocrinol Metab. 2023 Sep 14:dgad552. doi: 10.1210.
    >> Share

  330. UELAND GA, Ueland HO, Stokland AM, Bhan A, et al
    Prevalence, risk factors, clinical and biochemical characteristics of Alemtuzumab-induced Graves' disease.
    J Clin Endocrinol Metab. 2023 Sep 14:dgad540. doi: 10.1210.
    >> Share

  331. MENEGHINI V, Tebar WR, Santos IS, Janovsky CCPS, et al
    Potential determinants of thyroid peroxidase antibodies and mortality risk: results from the ELSA-Brasil study.
    J Clin Endocrinol Metab. 2023 Sep 12:dgad539. doi: 10.1210.
    >> Share

  332. POZDEYEV N, Dighe M, Barrio M, Raeburn C, et al
    Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant.
    J Clin Endocrinol Metab. 2023 Sep 8:dgad530. doi: 10.1210.
    >> Share

  333. RAMZY A, Saber N, Bruin JE, Thompson DM, et al
    Thyroid hormone levels correlate with the maturation of implanted pancreatic endoderm cells in patients with type 1 diabetes.
    J Clin Endocrinol Metab. 2023 Sep 6:dgad499. doi: 10.1210.
    >> Share

  334. AYALA IN, Soto Jacome C, Toro-Tobon D, Golembiewski E, et al
    Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study.
    J Clin Endocrinol Metab. 2023 Sep 1:dgad517. doi: 10.1210.
    >> Share

    August 2023
  335. FU J, Guan H
    The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
    J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.
    >> Share

  336. HUANG K, Su S, Wang X, Hu M, et al
    Association between maternal thyroid function in early pregnancy and gestational diabetes: a prospective cohort study.
    J Clin Endocrinol Metab. 2023 Aug 30:dgad518. doi: 10.1210.
    >> Share

  337. GILLIS A, Chen H, Wang TS, Dream S, et al
    Racial and Ethnic Disparities in the Diagnosis and Treatment of Thyroid Disease: a Mini- Review.
    J Clin Endocrinol Metab. 2023 Aug 30:dgad519. doi: 10.1210.
    >> Share

  338. MULLER I, Consonni D, Crivicich E, Di Marco F, et al
    Increased risk of Thyroid Eye Disease following Covid-19 Vaccination.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad501. doi: 10.1210.
    >> Share

  339. JU G, Sun Y, Wang H, Zhang X, et al
    Fusion oncogenes in patients with locally advanced or distant metastatic differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad500. doi: 10.1210.
    >> Share

  340. HA EJ, Lee JH, Lee DH, Moon J, et al
    Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study.
    J Clin Endocrinol Metab. 2023 Aug 25:dgad503. doi: 10.1210.
    >> Share

  341. HARAGUCHI T, Hamamoto Y, Kuwata H, Yamazaki Y, et al
    Effect of Roxadustat on Thyroid Function in Patients with Renal Anemia.
    J Clin Endocrinol Metab. 2023 Aug 19:dgad483. doi: 10.1210.
    >> Share

  342. STAN MN, Krieger CC
    The Adverse Effects Profile of Teprotumumab.
    J Clin Endocrinol Metab. 2023;108:e654-e662.
    >> Share

  343. MACHENS A, Lorenz K, Brandenburg T, Fuhrer-Sakel D, et al
    The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine.
    J Clin Endocrinol Metab. 2023;108:e734-e742.
    >> Share

  344. LI Z, Luo Y, Huang Q, Chen Z, et al
    A randomized clinical trial of intravenous methylprednisolone with two protocols in patients with Graves' Orbitopathy.
    J Clin Endocrinol Metab. 2023 Aug 14:dgad476. doi: 10.1210.
    >> Share

  345. HUANG PS, Cheng JF, Chen JJ, Wang YC, et al
    Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation.
    J Clin Endocrinol Metab. 2023 Aug 11:dgad448. doi: 10.1210.
    >> Share

  346. AGBAHT K, Sahin M
    Response to Letter to the Editor from Kleebayoon and Wiuwanikit: 'Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study'.
    J Clin Endocrinol Metab. 2023 Aug 9:dgad462. doi: 10.1210.
    >> Share

  347. LI H, Han R, Meng L, Sun Y, et al
    Nodal Metastases Associated with Fusion Oncogenes Are Age Dependent in Young Adult Patients with Thyroid Cancer.
    J Clin Endocrinol Metab. 2023 Aug 3:dgad458. doi: 10.1210.
    >> Share

    July 2023
  348. HAN S, Jeong S, Choi S, Park SJ, et al
    Association of thyroid hormone medication adherence with risk of dementia.
    J Clin Endocrinol Metab. 2023 Jul 29:dgad447. doi: 10.1210.
    >> Share

  349. KLEEBAYOON A, Wiwanitkit V
    Letter to the Editor from Kleebayoon and Wiuwanikit: 'Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study'.
    J Clin Endocrinol Metab. 2023 Jul 18:dgad428. doi: 10.1210.
    >> Share

  350. MERCADO M
    The Role of Androgen Receptors in Thyroid Cancer Biology: Beyond Sexual Dimorphism.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad424. doi: 10.1210.
    >> Share

  351. WANG JR, Zafereo ME, Wang W, Joshu C, et al
    Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma.
    J Clin Endocrinol Metab. 2023 Jul 15:dgad407. doi: 10.1210.
    >> Share

  352. TIAN T, Qi Z, Huang S, Wang H, et al
    Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
    J Clin Endocrinol Metab. 2023;108:2033-2041.
    >> Share

  353. ULDALL TORP NM, Liew Z, Carle A, Karmisholt J, et al
    Hyperthyroidism in Danish pregnant women during a 20-year period.
    J Clin Endocrinol Metab. 2023 Jul 12:dgad410. doi: 10.1210.
    >> Share

  354. ROJAS RAMOS JCR, Pelaez JM, Ono SE, Ramos CS, et al
    Cerebral cortical thickness morphometry and neurocognitive correlations in adolescents with congenital hypothyroidism.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad391. doi: 10.1210.
    >> Share

  355. NOEL JE, Sinclair CF
    Radiofrequency Ablation for Benign Thyroid Nodules.
    J Clin Endocrinol Metab. 2023 Jul 4:dgad357. doi: 10.1210.
    >> Share

    June 2023
  356. KAHALY GJ, Dolman PJ, Wolf J, Giers BC, et al
    Proof-of-Concept and Randomized, Placebo-Controlled Trials of an Fcrn Inhibitor, Batoclimab, for Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2023 Jun 30:dgad381. doi: 10.1210.
    >> Share

  357. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
    Response to Letter to the Editor From Devgan and Mayilvaganan: 'Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma'.
    J Clin Endocrinol Metab. 2023 Jun 28:dgad380. doi: 10.1210.
    >> Share

  358. DEVGAN Y, Mayilvaganan S
    Letter to the Editor from Devgan and Mayilvaganan: 'Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma'.
    J Clin Endocrinol Metab. 2023 Jun 28:dgad379. doi: 10.1210.
    >> Share

  359. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
    Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
    J Clin Endocrinol Metab. 2023 Jun 23:dgad369. doi: 10.1210.
    >> Share

  360. PLEIC N, Gunjaca I, Babic Leko M, Zemunik T, et al
    Thyroid function and metabolic syndrome: a two-sample bidirectional Mendelian randomization study.
    J Clin Endocrinol Metab. 2023 Jun 20:dgad371. doi: 10.1210.
    >> Share

  361. HA EK, Kim JH, Cha HR, Lee GC, et al
    Assessment of neurodevelopment and growth in congenital hypothyroidism: Serial 6-year follow-up study of 408 patients.
    J Clin Endocrinol Metab. 2023 Jun 19:dgad364. doi: 10.1210.
    >> Share

  362. SHAHA AR
    Aggressive Subtypes of Papillary Microcarcinoma.
    J Clin Endocrinol Metab. 2023;108:e489-e490.
    >> Share

  363. XIANG P, Ahmadi S, Coleman A, West W, et al
    Identifying and Predicting Diverse Patterns of Benign Nodule Growth.
    J Clin Endocrinol Metab. 2023;108:e458-e463.
    >> Share

  364. ETTLESON MD, Ibarra S, Wan W, Peterson S, et al
    Demographic, healthcare access, and dietary factors associated with thyroid hormone treatments for hypothyroidism.
    J Clin Endocrinol Metab. 2023 Jun 16:dgad331. doi: 10.1210.
    >> Share

  365. YEH MW
    The molecular landscape of thyroid nodules: Diagnostic and prognostic revelations from a large multicenter cohort.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad362. doi: 10.1210.
    >> Share

  366. YAN L, Zhen Y, Li Y, Li X, et al
    Five-year Outcome Between Radiofrequency Ablation vs. Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Jun 15:dgad360. doi: 10.1210.
    >> Share

  367. MORAN C, Chatterjee K
    Maternal Resistance to Thyroid Hormone beta and pregnancy outcomes.
    J Clin Endocrinol Metab. 2023 Jun 14:dgad350. doi: 10.1210.
    >> Share

  368. YUAN J, Liu X, Wang X, Zhou H, et al
    Association Between Educational Attainment and Thyroid Function: Results from Mendelian randomization and NHANES study.
    J Clin Endocrinol Metab. 2023 Jun 7:dgad344. doi: 10.1210.
    >> Share

  369. SATAPATHY S, Majeed AK, Ballal S, Bal C, et al
    Differentiated thyroid cancers in young adults versus children: Clinical characteristics and ten-year follow-up outcomes.
    J Clin Endocrinol Metab. 2023 Jun 7:dgad343. doi: 10.1210.
    >> Share

  370. DANNER E, Jaaskelainen J, Niuro L, Huopio H, et al
    Comorbidity in congenital hypothyroidism - A nationwide population-based cohort study.
    J Clin Endocrinol Metab. 2023 Jun 6:dgad334. doi: 10.1210.
    >> Share

  371. CATTONI A, Molinari S, Capitoli G, Masera N, et al
    Thyroid Function Tests in Children and Adolescents with Trisomy 21: Definition of Syndrome-Specific Reference Ranges.
    J Clin Endocrinol Metab. 2023 Jun 3:dgad333. doi: 10.1210.
    >> Share

  372. ZHOU Y, Wang Y, Zhang Z, Yin X, et al
    Male sex is not a risk factor for prognosis in postoperative thyroid cancer patients: a propensity score matching study.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad314. doi: 10.1210.
    >> Share

  373. SGRO D, Brancatella A, Greco G, Torregrossa L, et al
    Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad313. doi: 10.1210.
    >> Share

  374. BOJARSKY M, Baran JA, Halada S, Isaza A, et al
    Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy.
    J Clin Endocrinol Metab. 2023 Jun 2:dgad322. doi: 10.1210.
    >> Share

    May 2023
  375. LIN Y, Wu ZR, Shi YP, Ding M, et al
    Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
    J Clin Endocrinol Metab. 2023 May 23:dgad269. doi: 10.1210.
    >> Share

  376. CHOU CK, Chi SY, Hung YY, Yang YC, et al
    Clinical impact of androgen receptor-suppressing miR-146b expression in papillary thyroid cancer aggressiveness.
    J Clin Endocrinol Metab. 2023 May 23:dgad279. doi: 10.1210.
    >> Share

  377. CARLOMAGNO F, Minnetti M, Angelini F, Pofi R, et al
    Altered thyroid feedback loop in Klinefelter syndrome: a cohort study from infancy through the transition into adulthood.
    J Clin Endocrinol Metab. 2023 May 22:dgad281. doi: 10.1210.
    >> Share

  378. ALZAHRANI AS
    Clinical use of molecular data in thyroid nodules and cancer.
    J Clin Endocrinol Metab. 2023 May 18:dgad282. doi: 10.1210.
    >> Share

  379. MINASSIAN C, Allen LA, Okosieme O, Vaidya B, et al
    Preconception management of hyperthyroidism and thyroid status in subsequent pregnancy: a population-based cohort study.
    J Clin Endocrinol Metab. 2023 May 18:dgad276. doi: 10.1210.
    >> Share

  380. MULLER NA, Kaegi-Braun N, Durmisi M, Gressies C, et al
    Low T3 Syndrome on Admission and Response to Nutritional Support in Malnourished Medical Inpatients.
    J Clin Endocrinol Metab. 2023;108:e240-e248.
    >> Share

  381. WRIGHT JJ, Johnson DB
    Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction.
    J Clin Endocrinol Metab. 2023;108:1514-1525.
    >> Share

  382. NASR CE, Andrioli M, Endo M, Harrell RM, et al
    Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.
    J Clin Endocrinol Metab. 2023;108:1526-1532.
    >> Share

  383. RHEE CM, You AS, Narasaki Y, Brent GA, et al
    Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort.
    J Clin Endocrinol Metab. 2023 May 15:dgad261. doi: 10.1210.
    >> Share

  384. ZHANG Q, Jiao X, Lai X
    Clinical characters and influence factors of immune checkpoint inhibitor related thyroid dysfunction.
    J Clin Endocrinol Metab. 2023 May 15:dgad260. doi: 10.1210.
    >> Share

  385. SUN Y, Sun Q, Tian J, He X, et al
    Impact of waiting time for radioactive iodine therapy on outcome in N1 stage papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 May 11:dgad264. doi: 10.1210.
    >> Share

  386. INOUE K, Guo R, Lee ML, Ebrahimi R, et al
    Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter.
    J Clin Endocrinol Metab. 2023 May 5:dgad250. doi: 10.1210.
    >> Share

    April 2023
  387. LANG X, Zhao B, Fang S, Li L, et al
    Higher peripheral thyroid sensitivity is linked to a lower risk of heart failure after acute myocardial infarction.
    J Clin Endocrinol Metab. 2023 Apr 27:dgad240. doi: 10.1210.
    >> Share

  388. MUKHOPADHYAY P, Ghosh S
    Letter to the Editor From Mukhopadhyay and Ghosh: "The Use of Levothyroxine Absorption Tests in Clinical Practice".
    J Clin Endocrinol Metab. 2023 Apr 26:dgad239. doi: 10.1210.
    >> Share

  389. BATMAN A, Yazici D, Dikbas O, Agbaht K, et al
    Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study.
    J Clin Endocrinol Metab. 2023 Apr 25:dgad235. doi: 10.1210.
    >> Share

  390. ULLMANN TM, Sosa JA
    Delay in Surgery for Papillary Thyroid Cancer: A Proxy for Lower-Quality Care?
    J Clin Endocrinol Metab. 2023 Apr 21:dgad232. doi: 10.1210.
    >> Share

  391. ZHOU X, Iwama S, Kobayashi T, Ando M, et al
    The risk of thyroid dysfunction in PD-1 blockade is stratified by the pattern of TgAb and TPOAb positivity at baseline.
    J Clin Endocrinol Metab. 2023 Apr 21:dgad231. doi: 10.1210.
    >> Share

  392. CHIOSEA S, Hodak SP, Yip L, Abraham D, et al
    Molecular Profiling of 50,734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
    J Clin Endocrinol Metab. 2023 Apr 18:dgad220. doi: 10.1210.
    >> Share

  393. BIONDI B, Celi FS, McAninch EA
    Critical Approach to Hypothyroid Patients with Persistent Symptoms.
    J Clin Endocrinol Metab. 2023 Apr 18:dgad224. doi: 10.1210.
    >> Share

    March 2023
  394. ALSWAILEM M, Alghamdi B, Alotaibi A, Aljomiah A, et al
    Molecular genetics of diffuse sclerosing papillary thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad185. doi: 10.1210.
    >> Share

  395. KIM NE, Raghunathan RS, Hughes EG, Longstaff XR, et al
    Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
    J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210.
    >> Share

  396. ALZAHRANI AS
    The risk of expanding risk stratification in thyroid cancer.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad182. doi: 10.1210.
    >> Share

  397. CHAVES N, Broekhuis JM, Fligor SC, Collins RA, et al
    Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: a SEER-Medicare Analysis.
    J Clin Endocrinol Metab. 2023 Mar 29:dgad163. doi: 10.1210.
    >> Share

  398. TAYLOR P, Rajendram R, Hanna S, Wilson V, et al
    Factors predicting long-term outcome and the need for surgery in Graves Orbitopathy: extended follow-up from the CIRTED Trial.
    J Clin Endocrinol Metab. 2023 Mar 27:dgad084. doi: 10.1210.
    >> Share

  399. VAN VELSEN EFS, Verburg FA
    Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad171. doi: 10.1210.
    >> Share

  400. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
    Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
    J Clin Endocrinol Metab. 2023 Mar 25:dgad173. doi: 10.1210.
    >> Share

  401. MARIN L, Sabbadin C, Armanini D, Ambrosini G, et al
    Letter to the editor from Marin et al.: "The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography".
    J Clin Endocrinol Metab. 2023 Mar 23:dgad170. doi: 10.1210.
    >> Share

  402. MATHEWS DM, Peart JM, Sim RG, Johnson NP, et al
    Response to Letter to the Editor by Marin etal: "The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography".
    J Clin Endocrinol Metab. 2023 Mar 23:dgad169. doi: 10.1210.
    >> Share

  403. NASR CE
    Can one predict long-term growth of cytologically-benign thyroid nodules?
    J Clin Endocrinol Metab. 2023 Mar 22:dgad160. doi: 10.1210.
    >> Share

  404. JHA S, Welch J, Tora R, Lack J, et al
    Germline and somatic inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors.
    J Clin Endocrinol Metab. 2023 Mar 20:dgad136. doi: 10.1210.
    >> Share

  405. CARON P, Decleves X
    The use of levothyroxine absorption tests in clinical practice.
    J Clin Endocrinol Metab. 2023 Mar 14:dgad132. doi: 10.1210.
    >> Share

  406. AMARIKWA L, Mohamed A, Kim SH, Kossler AL, et al
    Teprotumumab-Related Hyperglycemia.
    J Clin Endocrinol Metab. 2023;108:858-864.
    >> Share

  407. LEVAILLANT L, Bouhours-Nouet N, Illouz F, Jager JA, et al
    The Severity of Congenital Hypothyroidism with Gland-in-situ Predicts Molecular Yield by Targeted NGS.
    J Clin Endocrinol Metab. 2023 Mar 8:dgad119. doi: 10.1210.
    >> Share

  408. TIAN Y, Yao D, Jin A, Wang M, et al
    Thyroid function in causal relation to MRI markers of cerebral small vessel disease: a Mendelian randomization analysis.
    J Clin Endocrinol Metab. 2023 Mar 7:dgad114. doi: 10.1210.
    >> Share

    February 2023
  409. POIRIER J, Godemel S, Mourot A, Grunenwald S, et al
    Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline.
    J Clin Endocrinol Metab. 2023 Feb 28:dgad115. doi: 10.1210.
    >> Share


  410. Retraction to "Thyroid Cancer Cell Resistance to Gefitinib Depends on the Constitutive Oncogenic Activation of the ERK Pathway".
    J Clin Endocrinol Metab. 2023 Feb 28:dgad056. doi: 10.1210.
    >> Share

  411. WONG CH, Leung EKH, Tang LCK, Lee CH, et al
    Response Letter to the Editor from Zhang et al.: 'Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism'.
    J Clin Endocrinol Metab. 2023 Feb 27:dgad093. doi: 10.1210.
    >> Share

  412. ZHANG Y, Zhu S, Gao Y
    Letter to the Editor from Zhang et al.: 'Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism'.
    J Clin Endocrinol Metab. 2023 Feb 27:dgad094. doi: 10.1210.
    >> Share

    November 2022
  413. DOTTORE GR, Lanzolla G, Comi S, Menconi F, et al
    Insights into the role of DNA methylation and gene expression in Graves' orbitopathy.
    J Clin Endocrinol Metab. 2022 Nov 6. pii: 6806119. doi: 10.1210.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016